Free Trial

ANGLE (AGL) Competitors

ANGLE logo
GBX 9.33 -0.42 (-4.28%)
(As of 12/20/2024 11:33 AM ET)

AGL vs. SSY, FME, BNR, CON, AMED, SHC, TALK, AMS, DXRX, and YGEN

Should you be buying ANGLE stock or one of its competitors? The main competitors of ANGLE include Scisys Group (SSY), Future Metals (FME), Burning Rock Biotech (BNR), Connemara Mining (CON), Amedeo Resources (AMED), Shaftesbury Capital (SHC), TalkTalk Telecom Group (TALK), Advanced Medical Solutions Group (AMS), Diaceutics (DXRX), and Yourgene Health (YGEN).

ANGLE vs.

Scisys Group (LON:SSY) and ANGLE (LON:AGL) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, institutional ownership, earnings, profitability, community ranking, valuation and media sentiment.

In the previous week, Scisys Group had 1 more articles in the media than ANGLE. MarketBeat recorded 1 mentions for Scisys Group and 0 mentions for ANGLE. Scisys Group's average media sentiment score of 0.68 beat ANGLE's score of 0.00 indicating that Scisys Group is being referred to more favorably in the media.

Company Overall Sentiment
Scisys Group Positive
ANGLE Neutral

18.8% of ANGLE shares are owned by institutional investors. 16.2% of ANGLE shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Scisys Group's return on equity of 0.00% beat ANGLE's return on equity.

Company Net Margins Return on Equity Return on Assets
Scisys GroupN/A N/A N/A
ANGLE N/A -63.75%-29.89%

Scisys Group has higher revenue and earnings than ANGLE. ANGLE is trading at a lower price-to-earnings ratio than Scisys Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Scisys Group£59.06M0.00N/A£1.40N/A
ANGLE£2.02M14.90-£18.03M-£0.07-133.33

ANGLE has a consensus target price of GBX 70, indicating a potential upside of 650.03%. Given ANGLE's stronger consensus rating and higher possible upside, analysts plainly believe ANGLE is more favorable than Scisys Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Scisys Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
ANGLE
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

ANGLE received 77 more outperform votes than Scisys Group when rated by MarketBeat users. Likewise, 62.33% of users gave ANGLE an outperform vote while only 42.34% of users gave Scisys Group an outperform vote.

CompanyUnderperformOutperform
Scisys GroupOutperform Votes
105
42.34%
Underperform Votes
143
57.66%
ANGLEOutperform Votes
182
62.33%
Underperform Votes
110
37.67%

Summary

Scisys Group and ANGLE tied by winning 7 of the 14 factors compared between the two stocks.

Get ANGLE News Delivered to You Automatically

Sign up to receive the latest news and ratings for AGL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AGL vs. The Competition

MetricANGLEDiagnostics & Research IndustryMedical SectorLON Exchange
Market Cap£30.10M£26.99M£5.14B£1.86B
Dividend Yield1.12%5.44%5.09%6.19%
P/E Ratio-133.332.0089.971,797.43
Price / Sales14.902,231.241,116.21380,062.11
Price / Cash5.8010.6642.8928.19
Price / Book1.172.754.782.92
Net Income-£18.03M£49.00M£120.23M£156.26M
7 Day Performance-15.15%-2.97%-1.92%-1.92%
1 Month Performance-15.15%-0.11%11.49%17.74%
1 Year Performance-17.04%-13.67%30.57%29.21%

ANGLE Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AGL
ANGLE
1.1054 of 5 stars
GBX 9.33
-4.3%
GBX 70
+650.0%
-20.6%£30.10M£2.02M-133.33650Gap Down
SSY
Scisys Group
N/AGBX 253
flat
N/A+0.0%£75.14M£59.06M180.711,376
FME
Future Metals
N/AGBX 0.75
-5.2%
N/A-53.0%£4.32M£552.00-92.20123,200Gap Down
BNR
Burning Rock Biotech
N/AGBX 3.56
-23.6%
N/A+363.2%£3.77MN/A0.001,390Gap Down
High Trading Volume
CON
Connemara Mining
N/AN/AN/AN/A£1.52MN/A-3.83N/ANews Coverage
AMED
Amedeo Resources
N/AGBX 3.50
flat
N/AN/A£0.00N/A0.0020,000
SHC
Shaftesbury Capital
2.3977 of 5 stars
GBX 127.60
-1.2%
GBX 165.67
+29.8%
-9.5%£2.49B£228.40M-3,190.003,000Gap Up
TALK
TalkTalk Telecom Group
N/AGBX 96.90
flat
N/A+0.0%£1.11B£1.52B7.57500News Coverage
High Trading Volume
AMS
Advanced Medical Solutions Group
1.7148 of 5 stars
GBX 202.50
-1.5%
GBX 300
+48.1%
-8.8%£434.46M£131.11M4,031.2410Gap Up
DXRX
Diaceutics
2.4138 of 5 stars
GBX 119.50
-1.2%
GBX 160
+33.9%
+34.9%£100.94M£26.09M-3,983.33151Analyst Forecast
News Coverage
High Trading Volume
YGEN
Yourgene Health
N/AGBX 0.52
flat
N/A+0.0%£16.43M£29.67M-51.50253

Related Companies and Tools


This page (LON:AGL) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners